Virtual Library

Start Your Search

Youjun Deng



Author of

  • +

    P1.01 - Advanced NSCLC (ID 158)

    • Event: WCLC 2019
    • Type: Poster Viewing in the Exhibit Hall
    • Track: Advanced NSCLC
    • Presentations: 1
    • Now Available
    • Moderators:
    • Coordinates: 9/08/2019, 09:45 - 18:00, Exhibit Hall
    • +

      P1.01-125 - Uniportal Versus Multiportal Thoracoscopic Lobectomy with Systematic Mediastinal Lymphadenectomy for N2(+) Stage III NSCLC (Now Available) (ID 1093)

      09:45 - 18:00  |  Presenting Author(s): Youjun Deng

      • Abstract
      • Slides

      Background

      With its growing popularity and potential better outcomes, uniportal(UP) thoracoscopic surgery has been used in the treatment of non small cell lung cancer(NSCLC). In this study,we aimed to evaluate the perioperative and long-term outcomes of uniportal thoracoscopic lobetectomy with systematic mediastinal lymphadenectomy for NSCLC in comparison to multiportal(MP) surgery in our institute.

      Method

      A total of 97 consecutive N2(+) stage III NSCLC patients were chosen to undergo thoracoscopic lobetectomy with systematic mediastinal lymphadenectomy in our institute from March 2013 to March 2018. Data such as clinicopathologic characteristics and perioperative outcomes, disease free survival(DFS) and overall survival(OS) were restrospectively reviewed in this article.

      Result

      There were 25 patients in the UP group, and 50 patients in the MP group from March 2013 to March 2018.UP group took less time than the MP group in the total operation duration (184.7 ± 69.5 vs 235.5 ± 79.9, P < 0.01).The conversion rate,the average dissected mediastinal lymph node stations,number of mediastinal lymph nodes dissected,the volume of estimated blood loss,volume of thoracic drainage,thoracic tube drainage time,length of postoperative hospital stay,perioperative complication were similar between the two groups(P >0.05). Postoperatively, UP and MP groups showed similar results in terms of disease free survival(DFS) and overall survival(OS).

      Conclusion

      In comparison with multiportal thoracoscopic surgery, UP thoracoscopic lobectomy with systematic mediastinal lymphadenectomy showed higher efficiency,and acquired equivalent perioperative short-term and long-term outcomes in the surgical treatment of N2(+) stage III NSCLCs. Further studies based on a larger population and better methodology are required to determine its further benefits towards patients.

      Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.

  • +

    P2.17 - Treatment of Early Stage/Localized Disease (ID 189)

    • Event: WCLC 2019
    • Type: Poster Viewing in the Exhibit Hall
    • Track: Treatment of Early Stage/Localized Disease
    • Presentations: 1
    • Now Available
    • Moderators:
    • Coordinates: 9/09/2019, 10:15 - 18:15, Exhibit Hall
    • +

      P2.17-43 - Complete Uniportal Thoracoscopic Anatomic Lung Resection with Systematic Mediastinal Lymphadenectomy for NSCLC (Now Available) (ID 899)

      10:15 - 18:15  |  Presenting Author(s): Youjun Deng

      • Abstract
      • Slides

      Background

      With its growing popularity and potential outcome, complete uniportal thoracoscopic surgery has been used in the treatment of thoracic diseases. This study aimed to summarize a personal experience of complete uniportal thoracoscopic anatomic lung resection with systematic mediastinal lymphadenectomy (CUT–ALR–SML) for non-small cell lung cancer (NSCLC) and to evaluate the feasibility and safety of CUT–ALR–SML in our institute.

      Method

      A total of 326 patients with NSCLC were chosen to undergo CUT–ALR–SML in our institute from August 2013 to July 2018. Data such as clinicopathologic characteristics and perioperative outcomes were restrospectively reviewed in this article.

      Result

      For the 326 cases of anatomic lung resection, the specific procedures and corresponding number of cases were as follows: segmentectomy, 90; lobectomy, 218; sleeve lobectomy, 9; ipsilateral lobe combined with segment resected synchronously (i-L+S), 6; and pneumonectomy, 3. A total of 31 cases required conversion to open surgery, and 4 cases were converted to multiportal thoracoscopic surgery. All patients underwent systematic mediastinal lymphadenectomy. The average mediastinal lymph node stations and mediastinal lymph nodes dissected under CUT–ALR–SML was 3.3±1.4 and 9.6±8.4,respectively. Approximately 99.7% of the patients acquired free resection margins. A total of 42 (12.9%) patients suffered from postoperative complications, and 1 patient died of pneumonia during the perioperative period.

      Conclusion

      Complete uniportal anatomic lung resection, particularly for segmentectomy and lobectomy is safe and feasible with low complication rates, and excellent free resection margin rates. Systematic mediastinal lymphadenectomy during complete uniportal thoracoscopic surgery adequately assesses the N2 lymph node. However, further studies need to be conducted to evaluate the role of CUT–ALR–SML in the treatment of NSCLC.

      Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.